Buy AKB-48 for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
AKB-48
APINACA, also known as AKB48, is a chemical compound that has recently been identified as a component in synthetic cannabis smoking mixtures. It is a potent agonist for the cannabinoid receptors, giving it a comparable effect to cannabis. Despite its recent discovery, it had never been reported in scientific or patent literature. This page explores the universe of APINACA, from its discovery and structure to its effects and potential risks.
Discovery of APINACA
In March 2012, Japanese labs identified APINACA as a component in synthetic cannabis smoking mixtures for the first time. It was discovered with a similar chemical, APICA. This finding propelled APINACA to the forefront of public interest, with many wanting to learn more about this intriguing drug.
Structure of APINACA
APINACA is structurally similar to cannabis compounds described in a University of Connecticut patent but has a simple pentyl chain at the 1-position of the indazole. APINACA comes under the patent's claims despite this resemblance, although it was not mentioned as an example. Because APINACA's structure closely mimics that of conventional cannabinoids, it has the potential to produce comparable effects on the body.
Agonist for Cannabinoid Receptors
With a Ki of 304.5nM and an EC50 of 585nM at CB1, APINACA is a moderately potent agonist for cannabinoid receptors. This indicates that it can bind to and activate the body's cannabinoid receptors, resulting in effects comparable to those of regular cannabis.
Potential Dangers of APINACA
It is crucial to highlight that while the discovery of APINACA has spurred curiosity about its possible benefits, there are also potential risks linked with its usage. It is crucial to approach any new chemical with caution, especially those without extensive investigation. APINACA's long-term consequences are unclear; prolonged usage may lead to significant health issues.
FAQ
What exactly is APINACA?
APINACA, commonly known as AKB48, was recently detected as a component of synthetic cannabis smoking mixtures.
Is APINACA legal?
The legality of APINACA differs between nations. It is categorized as a restricted substance in specific locations, but in others, it is not. Before utilizing APINACA, it is essential to verify local legislation.
What impacts does APINACA have?
As a potent agonist for cannabinoid receptors, the effects of APINACA are comparable to those of conventional cannabis. However, the long-term consequences of APINACA are unclear, and its usage might cause severe health issues.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics